Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.66 | 4e-06 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.55 | 0.0002 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.53 | 0.0002 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |